Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

News in brief

Aarti Drugs considers formulations driven plant acqusition

By Gareth MacDonald+


Aarti Drugs has said it is considering buying an unnamed manufacturer in Himachal Pradesh, India to expand its drug formulations business

The Mumbai-based drugmaker told the BSE about the potential takeover earlier today . The firm explained that it “has considered a proposal to acquire an undertaking/Company at Baddi in Himachal Pradesh to cater its existing business of Toll [contract] manufacturing of formulations as an initiative to have its own facilities for this business subject to necessary diligences and approval processes.”

Aarti operates two production facilities - in Tarapur, Maharashtra and Sarigam, Gujarat – at which it produces more than 50 bulk active pharmaceutical ingredients (API), several pharmaceutical intermediates and a range of speciality chemicals.

Details of the potential acquisition target were not provided.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Related products

Key Industry Events


Access all events listing

Our events, Events from partners...